Biota

May 2010

• "Antiviral options for influenza" presented by Dr Jane Ryan, Vice President, Product Development.
  5 May 2010: Bio International Convention 2010, Chicago, USA.

October 2009

• "Funding opportunities to support R&D - an industry perspective" presented by Dr Jane Ryan, Vice President, Product Development. 29 October 2009: AusBiotech 2009, Melbourne, Australia.

October 2008

• "Discovery of a new class of Inhibitors for Respiratory Syncytial Virus (RSV)" presented by Dr Alistair Draffan, Director, Drug Discovery. 8 October 2008: University of Adelaide, Australia.

 July 2008

• "Discovery of a new class of polycyclic RSV inhibitors" presented by Dr Alistair Draffan, Director, Drug Discovery.
  13-17 July 2008: 3D at the Cove, Drug Discovery and Development Conference, Queensland, Australia.

 June 2008

• "A novel chain termination assay: Application to HCV" presented by Dr Bo Lin, Senior Research Scientist, Drug Target Discovery.
  4-6 June 2008: Australian Centre for HIV and HCV (ACH2) Research Annual Workshop, Adelaide, Australia.

 May 2008

•  "From Structure to Function or You can't get there from here!" presented by Dr Craig Morton, Principal Research Scientist, Drug Target Discovery.
  22 May 2008: Tripos User Group meeting, Melbourne, Australia.

February / March 2008

• "Update on Antivirals for Respiratory Viruses" presented by Dr Jane Ryan, Vice President, Product Development.
  28 February - 2 March 2008: X International Symposium on Respiratory Viral Infections, Sentosa Island, Singapore.

 October 2007

•  "Current and future antivirals for influenza"presented by Dr Simon Tucker, Vice President, Research.
  4 -5 October 2007: Influenza Symposium, Canberra, Australia.

 August 2007

•  "Molecular Modelling from Structure to Function" presented by Dr Craig Morton, Principal Research Scientist, Drug Target Discovery.
  2-3 August 2007: Protein Expression Workshop held at CSIRO, Melbourne, Australia.

April / May 2007

• "Preclinical development of a new class of orally active drug candidates for the treatment of RSV infections" presented by Dr Chin Yu Lim, Senior Research Scientist, Chemistry.
  28-31 May 2007: The Conference & Expo of International Drug Discovery Science and Technology, China.
• "Discovery of a new class of polycyclic RSV inhibitors" and "Preclinical development of a new class of orally active drug candidates for the treatment of RSV infections" presented by Dr Alistair Draffan, Associate Director, Medicinal Chemistry.
  29 April - 3 May 2007: 20th International Conference on Antiviral Research (ICAR), Palm Springs, California, USA.
• "Characterisation of a new class of polycyclic RSV inhibitors" presented by Dr Simon Tucker, Vice President, Research.
  29 April - 3 May 2007: 20th International Conference on Antiviral Research (ICAR), Palm Springs, California, USA.

October 2006

• " A Novel Class of Nucleoside Inhibitors of HCV NS5b Viral Polymerase" presented by Dr John Lambert, Executive Director, Drug Discovery.
  26 October 2006: "First International Workshop on Hepatitis C Resistance and New Compounds", Radisson Hotel, Boston, USA.
• "Becoming a product-driven enterprise - product-driven R&D project management from discovery to market" presented by Dr John Lambert, Executive Director, Drug Discovery.
  4 October 2006: "Maximising Drug Discovery and Development ROI", Rendezvous Hotel, Melbourne, Australia.

August 2006

• "Inhibitors of HCV NS5b Viral Polymerase:A Novel, Potent Class of Nucleoside Analogues" presented by Dr Craig Morton, Principal Research Scientist, Drug Discovery.
  27-31 August 2006: 13th International meeting on Hepatitis C Virus & Related Viruses, Cairns, Australia.

June 2006

• "Careers in Biotechnology" presented by Dr Simon Tucker, Vice President, Research.
  Careers Teacher Symposium at Monash University, Melbourne, Australia.

May 2006

• "Computational Drug Design" presented by Dr Craig Morton, Principal Research Scientist, Drug Discovery.
  30 May 2006: CSIRO Molecular and Health Technologies, Melbourne, Australia.
• "Practical lessons for doing business in Japan, Biota's experience" presented by Dr Jane Ryan, Vice President, Product Development.
  30 May 2006: Victorian Government Seminar, Melbourne, Australia.
• "Antivirals for H5N1 Influenza" presented by Dr Simon Tucker, Vice President, Research.
  23 May 2006: St Vincent's Institute for Medical Research, Melbourne, Australia.

April 2006

• "Antivirals for Avian Influenza" presented by Dr Simon Tucker, Vice President, Research.
  9-12 April 2006: Bio 2006 Chicago, Illinois.
• "Thanks for the memories: structure-based drug discovery", presented by Professor Michael Parker.
  Howard Florey Institute, Melbourne, Australia.
• "The life cycle of a pore-forming toxin" presented by Professor Michael Parker.
  Bio21 Institute and Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Australia.

March 2006

• "Novel Flu Antivirals", presented by Dr Jane Ryan, Vice President, Product Development.
  16-19 March 2006: VIII International Symposium on Respiratory Viral Infections, Hawaii.
• "Thanks for the memories: structure-based drug discovery" presented by Professor Michael Parker.
  Department of Medicine, Austin Hospital, Melbourne, Australia.

February 2006

• "Working Globally" presented by Dr Jane Ryan, Vice President, Product Development.
  27-28 February 2006: AIRG Annual Conference, Melbourne, Australia.

December 2005

• "A Novel, Potent and Drug-Like Class of Inhibitors of HCV NS5b Viral Polymerase" presented by Dr John Lambert, Executive Director, Drug Discovery.
  11-15 December 2005: HEPDART 2005 Frontiers in drug development for viral hepatitis, Hawaii.